Assembly of leukosomes
Leukosomes were prepared using the thin layer evaporation (TLE) method 1 Leukosomes were stored at 4°C until use.
Physical characterization of leukosomes

Dynamic light scattering analysis
Vesicle's size and polydispersity index were determined through dynamic light scattering analysis using a Nanosizer ZS (Malvern Instruments) that permitted also to evaluate their surface charge. 20 µl of liposome and leukosome suspensions were diluted in bidistilled water and seven measurements were performed with 20 runs each and the results averaged.
CryoEM analysis
For electron microscopy analysis, lipid vesicles were plunge-frozen on holey film grids (R2x2 Quantifoil®; Micro Tools GmbH, Jena, Germany) as previously reported 2 . We have used a 626 cryo-specimen holder (Gatan, Inc., Pleasanton, California) for imaging.
Data were collected on a JEOL 2100 electron microscope. Images were recorded under low electron-dose conditions (∼5 -20 electrons/Å2) using a 4,096 x 4,096 pxl CCD camera (UltraScan 895, GATAN, Inc.) at nominal magnifications of 20,000x. 
Atomic Force Microscopy (AFM) analysis
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Fourier Transform Infrared spectroscopy (FTIR) analysis
FTIR measurements in attenuated total reflection (ATR) were performed using a single reflection diamond element. The FTIR spectrometer Nicolet equipped with nitrogen cooled mercury cadmium telluride detector and an air purging system, was employed under the following conditions: 2 cm −1 spectral resolution, 20 kHz scan speed, 1000 scan co-addition, and triangular apodization. Each sample was dissolved at a final concentration of 1 mg ml -1 in PBS. 5 µl of each sample were deposited on the ATR plate and spectra were recorded after solvent evaporation to allow the formation of a hydrated lipid film. After these measurements, the same samples were re-suspended, and the spectra were recorded again after the solvent evaporation for three times in order to confirm the data. The ATR/FTIR spectra were reported after background subtraction and normalization on the C=O vibrational mode located at ≈1730 cm -1 band area to compensate for possible differences in the lipid content.
Differential scanning calorimetry (DSC) analysis
Leukosomes with different protein/lipid ratio (1:100, 1:300, 1:600) were prepared for DSC measurements using a Mettler-Toledo Star DSC (Mettler-Toledo, Switzerland ).
Liposomes were used as control, to evaluate differences in the bilayer thermal transitions with increasing protein content. A concentrated aqueous suspension of the samples was placed in an alumina pan for analysis, and an empty pan was used as reference. The heating scan was from 25 to 60 °C at the rate of 5 °C/min. DSC curves were analyzed using the fitting program. Reactions were stopped by changing the pH of the solution, and by adding 0.5% of trifluoroacetic acid. A Waters Corp. NanoAcquity UPLC system coupled with a Synapt HDMS (G1) mass spectrometer was employed. The peptide mixtures were separated with a reverse phase C-18 column and then injected into the mass spectrometer in positive ion (ESI) mode. The LC system consisted of a 180um x 20mm Symmetry C18 (5um particle) trapping column, and a 75um x 250mm BEH130 C18 (1.7um particle)
Analysis of leukosome protein composition
analytical column. Peptide separation was carried out by a 3-40% gradient of solvent B (0.1% formic acid in acetonitrile) in solvent A (0.1% formic acid in water) over 120min at flow of 0.3ul/min and a column temperature of 35°C. The mass spectrometer was operated in the data independent (parallel-ion fragmentation) MS E mode 5-7 at a capillary voltage of 3kV, with alternating low (6V) and ramped high collision energies (15V-45V)
at a scan rate of 1.2sec per scan. The Glu-fibrinopeptide B (GFP) was sampled every 30secs as internal calibrant. All data was collected with the time of flight (TOF) detector set in the V-mode (resolution ~10,000). All LC/MS instrument control and data acquisition was accomplished using MassLynx (v4.1) software from Waters Corp. The samples were analyzed in triplicate.
Protein identification and classification
For protein identification and quantification we employed ProteinLynx Global Server (PLGS v2.4; Waters Corp) software, using both the IdentityE and ExpressionE algorithms included in the software. Precursor ions and fragment ion mass error tolerance levels (typically less than 5ppm and 15ppm respectively) were calculated automatically by the software. The Uniprot 2013_03 ('reviewed') (16,614 entries) complete mouse proteome database was interrogated. The false discovery rate (FDR)
for protein identifications was set at 1%. Peptide identifications were accepted with a minimum of 2 peptides and 7 fragment ions matched per protein, with a minimum of 4 fragment ions per peptide detected. As database search parameters, we selected a)
carbamidomethyl-cysteine as fixed modification, b) oxidized-methionine as variable modification, c) and one trypsin miscleavage. All protein identifications were further filtered to retain only those protein IDs that remained above the 95% confidence interval.
The whole protein data set (Table) 
Evaluation of protein orientation into leukosome bilayer
Flow cytometry analysis was performed to validate the presence of leukocyte-derived membrane proteins and to confirm their correct orientation into leukosome bilayer.
Leukosomes and liposomes were diluted in FACS Buffer (PBS, 1% BSA) to a final concentration of 0.5 mM and incubated separately with FITC-labeled anti-Mac-1 and anti-LFA-1, PerCP-labeled anti-CD45, PE-labeled PSGL-1 and CD18, and AlexaFluor 647-labeled CD47 (2.5 µg/ml) designed to bind the protein's extracellular domain for at least 30 min at room temperature. Samples were next dialyzed using 1000 kDa membrane filters for 1.5 h in water covered from light with mild stirring and then analyzed on the flow cytometer. The analysis was performed also after dexamethasone loading to verify whether drug encapsulation affects surface properties.
Characterization of protein glycosylation
Glycosylation of membrane-associated proteins was verified using the wheat germ 
In vivo experiments
All animal experiments were performed in accordance with the guidelines of the Animal 
Intravital experiments
Imaging of particle accumulation in ear
Anesthetized animals were placed and imaged on an upright Nikon A1R MP-ready laser scanning intravital confocal microscopy (IVM) platform equipped with a resonance scanner, isoflurane anesthesia system, heated stage, and custom coverslip mounts.
Before imaging, a bolus injection of 70 kDa FITC-dextran (50 µL in PBS) was used to delineate the vasculature. Images were obtained with a three-channel setup in which fluorescence was collected at 488/525 nm for FITC dextran, and at 561/579 nm for rhodamine-labeled particles. Image acquisition was performed over selected field of views (FOVs) with resolution of 512 x 256 pixels with an optical slice thickness of 7.1 µm. Imaging to determine extent of leukosomes was performed 1 h and 24 h after the initial i.v. injection (50 µL, 1 mg/mL).
Image analyses and particle quantification
The average number of particles (leukosomes or liposomes) preferentially accumulated in ear microenvironment was enumerated in video stills using Nikon NIS element AR software (Nikon, Mellville, NY). Select FOVs were chosen from time-lapse videos and automated object measurement feature was used to calculate area fraction fluorescent particles in each frame where a particle was defined by setting low and high pixel thresholds to include only visible red fluorescent particles and to exclude single noise pixels. The settings were applied to all frames and automated counting function used to generate average area fraction of particles for each time point. These settings were also kept constant across treatment groups. The average area fraction covered by fluorescent particles was normalized to the imaging area and then plotted as a function of time.
Biodistribution and pharmacokinetic profile of leukosomes
Balb/c mice were i.v. injected with 2 mg of rhodamine-labeled liposomes and leukosomes (n=5 for each group) in order to evaluate particle biodistribution and pharmacokinetic profile. After 24 h, mice were sacrificed and major organs (kidney, liver, kidney, and lung) and ear tissue were collected, washed twice with PBS, weighted and transferred in a falcon tube. Tubes were then filled with formamide (1 ml per 100 mg of tissue weight) and tissues were homogenized. After 2 h of incubation at room temperature, samples were centrifuged at 5,000 g per 10 min and supernatant was collected and spectrofluorometrically analyzed for rhodamine detection (excitation/emission 561/579; slit width, 5 nm). Results are represented as relative signal per organ (%) based on a standard curve to calibrate rhodamine-labeled phospholipid.
For pharmacokinetic studies, blood was collected from the retro orbital plexus (n=5 for each group) at 24 h after injection, and centrifuged at 1,500 rpm for 10 min to isolate plasma. Rhodamine concentration was measured based on fluorescence and calculated as aforementioned.
Bioluminescence imaging of lipopolysaccharide-induced acute ear inflammation
Bioluminescence imaging of mice was used to confirm local inflammation. The right ears of mice were inflamed with a subcutaneous injection of 10 µL of LPS. Mice were imaged for bioluminescence (BLI) 5 min after i.p. administration of 5 mg (250-300 mg/kg) of luminol (Sigma Aldrich) for 5 min at medium binning and an f/stop of 1 on a IVIS Spectrum. Luminol is a small molecule that enables noninvasive bioluminescence imaging of myeloperoxidase 8 (an enzyme found only in activated phagocytes, such as neutrophils). Images were analyzed using the Living Image Software and the average radiance in both ears was collected.
Statistical analysis
GraphPad statistical software (La Jolla, CA) was used to compute statistical significance between groups and control using student's test and one-way ANOVA test to compare differences between groups. A value of p = 0.05 was considered statistically significant.
Intravital microscopy data are presented as means ± standard deviation obtained from at least 10 field of views (FOVs) for n = 3. The allocation of the animals to the different groups of treatment was at random. To diminish the occurrence of bias, the experiments were done "blind". 
